Advertisement

AIDS-HIV News: Breaking AIDS-HIV News, Comments and Articles. - Page: 4

22:35 EDT 25th May 2013 | BioPortfolio

AIDS-HIV News - Page: 4 RSSTwitter

Read the latest AIDS-HIV News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on AIDS-HIV.

Search or Follow Our AIDS-HIV - Page: 4 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More AIDS-HIV - Page: 4 News.
You can also follow our AIDS-HIV - Page: 4 news stories on Twitter: @HIVAID_Bio

Showing "AIDS acquired immunodeficiency" News Articles 76 to 100 of 6,900+

Tuesday 21st May 2013

Graston Technique® Acquired by New Entity

INDIANAPOLIS -- Graston Technique,® a manufacturer of instrument-assisted soft tissue dysfunction treatment and rehabilitation products, announced May 8 that it has been acquired by a newly formed Indianapolis-based entity. Michael I. Arnolt, president and co-founder of TherapyCare Resources Inc., the owner of GT, and Todd R. Lugar, president and CEO of the acquirer, Graston Technique LLC...

Mechanism discovered which aids Legionella to camouflage itself in the organism

(Elhuyar Fundazioa) Research led by the Basque biosciences research center, CIC bioGUNE, in which teams from the National Institute of Health of the USA and the National Supercomputation Centre in Barcelona have also participated, has described for t...

Sangamo BioSciences Presents New Data From In Vivo Protein Replacement Platform For Development Of ZFP Therapeutics® For Monogenic Diseases

RICHMOND, Calif., May 20, 2013 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced the presentation of new data demonstrating the successful application of Sangamo's proprietary In Vivo Protein Replacement Platform (IVPRP) to produce therapeutically relevant levels of Factor VIII in a mouse model.  Sangamo has partnered with Shire AG (LSE: SHP, NASDAQ: SHPG)...

HarborPath Receives $250,000 Elton John AIDS Foundation Grant to Support Program Expansion

COLUMBIA, S.C., May 20, 2013 /PRNewswire/ -- HarborPath, an organization which provides a single point of access to HIV/AIDS medications through patient assistance programs, has been awarded a $250,000 grant from the Elton John AIDS Foundation. The grant funding will be used to expand HarborPath's services and help more uninsured individuals living with HIV/AIDS gain access to their life-...

Workshops Offered To Identify Underlying Challenges That Put Strain On Relationships

Texas Counseling is helping couples sift through the elements that strain their relationships and help develop solutions through their Sexuality and Relationship Workshops and individualized counseling sessions. Dallas, Texas (PRWEB) May 21, 2013 Modern couples have countless strains on their relationships. With the help of Texas Counseling’s Sexuality and Relationship Workshops, couples are le...

[Cardiac Science] divests its diagnostic cardiology line to [Mortara Instrument]

Two years after being acquired by [Opto Circuits (India) Ltd.], [Cardiac Science Corp.] has sold its diagnostic cardiology product line to [Mortara Instrument Inc.] (diagnostic electrocardiography devices).

[Life-Tech] sells anesthesia business to [Kimberly-Clark]

Personal and health care company [Kimberly-Clark Corp.] (K-C) has acquired the anesthesia business of [Life-Tech Inc.] (formerly neurological and urological devices).

Starkey Hearing Foundation Offers Assistance in Oklahoma

Foundation pledges hearing help to people affected by tornado Starkey Hearing Foundation is offering free assistance to those who may have suffered hearing loss or lost their hearing aids as a result of the devastating tornado around Oklahoma City on Monday. This is a time when many come together to extend caring hands. The reflected light of...

Novo A/S acquires Xellia

Novo A/S (Hellerup, Denmark) will acquire infectious disease company Xellia Pharmaceuticals A/S (Oslo, Norway) from private equity firm 3i Group for about $700 million. In 2008, 3i acquired Xellia, which develops and manufactures active pharmaceutica...

U.S. Renal Care pays $7.3 million to settle billing fraud case brought by nurse-whistleblower

BALTIMORE, May 21, 2013 /PRNewswire/ -- U.S. Renal Care has agreed to pay $7.3 million to the federal government to settle a whistleblower lawsuit brought by a nurse that alleged a company U.S. Renal Care acquired, Dialysis Corporation of America (DCA), overcharged Medicare for years for an anemia drug used to treat dialysis patients. The "qui tam" (whistleblower) lawsuit alleged that DCA wa...

New Zealand declines Alexion's funding application for Solaris

New Zealand's Pharmaceutical Management Agency PHARMAC is seeking feedback on a proposal to decline the application from USA-based drugmaker Alexion Pharmaceuticals (Nasdaq: ALXN) for funding its drug Solaris (eculizumab) for the treatment of paroxys...

AHF: Global AIDS Patients, Doctors Lobby Congress on PEPFAR Reauth

AIDS patients and doctors from South Africa, Uganda, Nigeria, Haiti and Vietnam will visit 50 congressional offices this week to tell their personal stories and press legislators to continue to honor the US’ commitment to PEPFAR, the respected global AIDS care program Five AIDS treatment clients, three doctors and one board member from AIDS Healthcar...

TRADE NEWS: Agilent Technologies Introduces OpenLAB Data Store for Mass Spectrometry

Networked Solution Provides Compliant Storage of ICP-MS Data Agilent Technologies Inc. (NYSE: A) today announced OpenLAB Data Store for MS, a simple and affordable networked solution for compliant storage of mass spectral data acquired with Agilent’s ICP-MS MassHunter system. The software is designed for medium to small laboratories measuring inorgan...

Norway’s Xellia Pharma Acquired By Novo A/S In $700 Million Buyout

3i sells Nordic antibacterial manufacturer Xellia Pharmaceuticals, which has plans to develop novel antibiotics, new formulations and new bulk generics.

Elixir Medical Announces Excellent Six-Month Safety and Efficacy Results for the CE-Marked Fully Bioresorbable DESolve® Novolimus Eluting Coronary Scaffold System at Late Breaking Clinical Trial Session of EuroPCR

Data show an increase in the scaffold and lumen area, re-establishing the vessel’s natural ability to positively remodel at 6 months Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced excellent six-month clinical trial results today from the DESolve Nx in...

Huru International Celebrates 5 Years Helping African Girls Stay in School with An International Children's Day Challenge

Huru re-useable sanitary napkin and hygiene kits donated on the week of June 1, 2013 will be matched by Micato Safaris New York, NY (PRWEB) May 21, 2013 In celebration of nonprofit foundation Huru International’s fifth year, providing African girls with Huru Kits – backpacks filled with re-useable sanitary pads, life-saving HIV/AIDS prevention information, and other vital information and reso...

Baxter Receives Marketing Authorization for HyQvia in European Union

Baxter International Inc. (NYSE:BAX) and Halozyme Therapeutics, Inc., (NASDAQ:HALO) today announced that the European Commission has granted Baxter marketing authorization in all European Union (EU) Member States for the use of HyQvia (solution for subcutaneous use) as replacement therapy for adult patients with primary and secondary immunodeficiencies....

Imprivata Appoints Rodger Weismann to Board of Directors

Former Phase Forward Chief Financial Officer Brings More than 40 Years of Software and Services Experience to Imprivata as Company Continues Rapid Growth Imprivata®, a global leader in healthcare IT security solutions, today announced that Rodger Weismann has been appointed to the company’s Board of Directors and will serve as Chairman of the...

Ignyta acquires Actagene Oncology and entry into cancer personalized medicine

Privately-held US biotechnology company, Ignyta, which engages in catalyzing personalized medicine in autoimmune diseases, says it has acquired Actagene Oncology, effective May 20. Actagene was a San Diego-based privately held biotechnology company f...

Novo holding company buys Norwegian Xellia

COPENHAGEN, May 21 (Reuters) - Novo A/S, the holding company of Danish insulin producer Novo Nordisk, on Tuesday said it had acquired Norwegian-based Xellia Pharmaceuticals for about $700 million.

FDA Review Staff Look Into Efficacy Of High Dose Sleep Drug

Lawrence LeBlond for redOrbit.com - Your Universe Online An experimental insomnia drug from Merck & Co has been shown to be effective, but reviewers with the US Food and Drug Administration (FDA) are questioning the drug’s dosage levels. The comments, posted on the agency’s website Monday, come ahead of a meeting of external medical experts which will advise on whether the drug, called su...

New Hearing Healthcare Blog from Audiology & Hearing Clinic in Paris TN Connects Local Residents with Vital Information on Hearing Aids, Hearing Loss and Tinnitus

The audiologists and hearing specialists at Audiology & Hearing Clinic in Paris TN have launched a weekly blog to share expert hearing care information and tips. Paris, TN (PRWEB) May 21, 2013 To share hearing health advice with local residents on an ongoing basis, Audiology & Hearing Clinic in Paris TN recently created a blog on the practice website. The recently created blog will showc...

MAQUET Cardiovascular Acquires LAAx Inc. And Its TigerPaw® System II Occlusion Device To Expand Cardiac Surgery Offering

WAYNE, N.J., May 21, 2013 /PRNewswire/ -- MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, today announced that it has acquired LAAx Inc., a privately held company that has developed a unique mechanical occlusion device called the TigerPaw® System II ("TigerPaw II"). When implanted, TigerPaw II safely and effectively occludes the left atrial appendage (LAA) and co...

Federal Appellate Court Rules in Favor of Mylan in Patent Infringement Litigation Relating to Sunovion's Brovana® Product

PITTSBURGH, May 21, 2013 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that the Court of Appeals for the Federal Circuit has ruled in favor of Mylan Specialty L.P., f/k/a Dey Pharma, L.P. and has reversed the District Court's decision invalidating five of Mylan's patents related to Perforomist®. The Court's reversal of the summary judgment decision reinstates Mylan Specialty's pate...

Net Health Acquires Integritas, Urgent Care and Occupational Health Leader

PITTSBURGH, May 21, 2013 /PRNewswire/ -- Net Health, the leading provider of clinical solutions for outpatient specialty care, announced today the acquisition of Integritas, Inc., a provider of integrated clinical EMR and practice management solutions for the growing urgent care, occupational health, and hospital employee health markets. "Strategically, we were drawn to the rapidly growing a...


Search BioPortfolio:
Advertisement

News Quicklinks

Advertisement